|April 8, 2015Eurasian Economic Commission, Smolenskiy Boulevard, 3/5, building 1||Round Table “State and perspectives of bioeconomy development in the EurAsian Union"|
|March 30, 2015 at 7.00 PMMoscow, 14, build.15, 2nd Tverskaya-Yamskaya, Co-working Centre "Boiling Point"||Discussion club 2045. Lecture “The middle of XXI century: what can be awaited beyond the horizon?”|
|February 9-12, 2015Moscow, Centre of Innovative Development "TechnoPolis-Moscow"||XXVII Winter Youth scientific school “Perspective outlooks in physical and chemical biology and biotechnology”|
|October 28-29, 2010St. Petersburg, Hotel AZIMUT||Tech Transfer Summit|
The chemical giant Monsanto was established 1901 and was engaged primarily in food additives , until it began to develop genetically modified products at the same time when the medical research his field has commenced. But doctors marked their first success in 1982 when the first recombinant insulin was licensed, the Monsanto chemists had to run a much longer way until GM corn was developed.
Presently, Monsanto is number one company in this field. In the fiscal year 2009 Monsanto sold genes and seed for $7.3 billion outstripping the second in raw DuPont ($4billion).More
The tooth enamel is known to be destroyed by the impact of milk acid which synthesizes bacteria inhabiting mouth cavity. The scientists of
A large farm can’t use the traditional scheme of stockbreeding wastes utilization envisaging extended quarantine of dung in tanks. The contact of dung with environment presents a serious danger to ecology. “Talina” employs a microbiological utilization. Microbiological and enzyme preparations are introduced to dung bath adjusted under mesh bottom. Biopreparations enhance dissolution of organic matters causing a bad smell.More
The government of Kraskojarsk kray has announced the open tender for establishing a nanotechnology center . The principal purposes of the contest is the creation of the
The new lab opened in
Indian mass-media cite the opinion of Mr Vasilov President and CEO of the Russia Biotechnology Society expressed last week during his visit to India "The «Russian biotechnology is going to establish partner relation and to create joint ventures with Indian companies. Our Society joints over 4000 members , they are eager to collaborate with Indian biotechnological and pharmaceutical firms, to commercialize innovations , to establish joint ventures." Russia is especially interested in vaccines, agrobiotechnology, nanobiotechnologies, bioinformatics, as well as in clinical trials.
During his stay Mr. Vasilov paid a visit to Genoma Valley and was impressed by the progress of such renown companies as Bharat Biotech and Vimta Labs.Mr Vasilov told that a large Russian delegation will take part in the 7th International Forum BioAsia, which will be held February, 3-6 in Haidarabad the famous scientific and technological stronghold of India. "BioAsia" forum hosts major international players active in the filed of biotechnology, biopharmaceutucs, agrobiotechnology. Mr. Vasilov anticipates that the ppropriate decisions concerning Russia's investments will be taken in the frame of the Forum.More
In the frame of the mutual
The union of states „EurAs“ ES combines 5 states :
Since 2008 cancer became the “killer Nr.1” in the country. The principle reasons are smoking, obesity, alcohol addiction.More